ResultsIQ › Latest results › MPS Limited
MPS Limited Q2 FY27 results deck summary
NSE: MPSLTD · BSE: 532440
Results deck of 3 Nov 2026, summarised by AI from the filing.
Q2 FY27 EBITDA rose 27.39% to ₹7,703 lakh at a record 34.34% margin, with FY27 EBITDA guided at ₹300 cr+.
Key takeaways
- Q2 EBITDA EBITDA ₹7,703 lakh, up 27.39% YoY, at a record 34.34% margin vs 31.10%, while revenue rose 15.35% to ₹22,429 lakh.
- FY27 guidance Management guides FY27 EBITDA of ₹300 cr+ and expects to clear it comfortably after H1 EBITDA of ₹154 cr.
- Education mix Education rose to 30.6% of revenue from 27.2% as Unbound Medicine scaled, while its segment margin fell to 30.42% from 42.12%.
- AI productivity AI-enabled production in Research, priced on output, lifted segment EBITDA margin to 48.17% and EBITDA per employee to ₹2.17 lakh.
MPS Limited Q2 FY27 results
As filed: Revenue ₹224 cr (+16% year on year), EBITDA ₹77.0 cr (+28% year on year), PAT ₹52.1 cr (−5% year on year), EBITDA margin 34.3% (+342 bps).
The Q2 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹224 cr (+21% year on year), EBITDA ₹77.0 cr (+51% year on year), PAT ₹50.4 cr (+44% year on year), EBITDA margin 34.3% (+690 bps). Score 73 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA growth was well above it; profit growth was above it. EBITDA margin rose 690 bps year on year. Profit rose ₹15.4 cr on a year ago, more than the ₹9.0 cr it added the year before. Share price after the results: +36.5% in 30 days (Nifty 500: +0.7%).
- Q4 FY26: Revenue ₹205 cr (+13% year on year), EBITDA ₹67.5 cr (+21% year on year), PAT ₹47.0 cr (0% year on year), EBITDA margin 32.9% (+214 bps). Score 54 of 100, In line with trend. Revenue and profit growth were below the company's own trend; EBITDA growth was above it. EBITDA margin rose 214 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −1.0% in 28 days (Nifty 500: +0.3%).
- Q3 FY26: Revenue ₹182 cr (−2% year on year), EBITDA ₹57.6 cr (−4% year on year), PAT ₹35.5 cr (−3% year on year), EBITDA margin 31.6% (−71 bps). Score 27 of 100, Below trend. Revenue and EBITDA growth were well below the company's own trend; profit before exceptional items growth was below it. EBITDA margin fell 71 bps year on year. Revenue fell 6% from last quarter. Share price after the results: −24.8% in 30 days (Nifty 500: −1.9%).
- Q2 FY26: Revenue ₹194 cr (+9% year on year), EBITDA ₹60.0 cr (+13% year on year), PAT ₹55.0 cr (+17% year on year), EBITDA margin 30.9% (+115 bps). Score 46 of 100, In line with trend. Revenue growth was below the company's own trend; EBITDA and profit before exceptional items growth were in line with it. EBITDA margin rose 115 bps year on year. Profit before exceptional items rose ₹8.0 cr on a year ago, more than the ₹7.0 cr it added the year before. Share price after the results: −13.5% in 30 days (Nifty 500: −0.5%).
- Q1 FY26: Revenue ₹186 cr (+3% year on year), EBITDA ₹51.0 cr (+24% year on year), PAT ₹35.0 cr (+35% year on year), EBITDA margin 27.4% (+477 bps). Score 50 of 100, In line with trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were above it. EBITDA margin rose 477 bps year on year. Profit fell 26% from last quarter. Share price after the results: −13.1% in 27 days (Nifty 500: −2.6%).
- Q4 FY25: Revenue ₹182 cr (+22% year on year), EBITDA ₹56.0 cr (+33% year on year), PAT ₹47.0 cr (+62% year on year), EBITDA margin 30.8% (+258 bps). Score 80 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 258 bps year on year. Revenue rose ₹33.0 cr on a year ago, more than the ₹22.0 cr it added the year before. Share price after the results: +2.1% in 28 days (Nifty 500: +0.2%).
- Q3 FY25: Revenue ₹186 cr (+39% year on year), EBITDA ₹60.0 cr (+33% year on year), PAT ₹41.0 cr (+37% year on year), EBITDA margin 32.3% (−132 bps). Score 74 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin fell 132 bps year on year. Consolidated profit +37% but standalone -9%.
Past price moves after results do not indicate future moves. Not a recommendation.
MPS Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Earnings call (4 Nov 2026), Results deck (3 Nov 2026)
- Q1 FY27: Earnings call (22 Jul 2026), Results deck (21 Jul 2026)
- Q4 FY26: Earnings call (18 May 2026), Results deck (15 May 2026)
- Q3 FY26: Earnings call (2 Feb 2026), Results deck (2 Feb 2026)
- Q2 FY26: Earnings call (12 Nov 2025), Results deck (12 Nov 2025)
- Q1 FY26: Earnings call (18 Jul 2025), Results deck (18 Jul 2025)
- Q4 FY25: Earnings call (16 May 2025), Results deck (16 May 2025)
- Other events: Special call (18 Feb 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.